Demetriou D, Sebeikat D
Urologische Klinik, Leopoldina-Krankenhaus der Stadt Schweinfurt.
Dtsch Med Wochenschr. 1996 Dec 6;121(49):1526-30. doi: 10.1055/s-2008-1043178.
To assess survival length and quality of life in patients with a percutaneous nephrostomy (PN) for malignant tumour and postrenal anuria.
Case records were analysed of 50 patients (39 men, eleven women; mean age 65.6 years) with postrenal anuria due to malignancy who had undergone ultrasound-directed PN under local anaesthesia for urinary drainage. Particular attention was paid to the course of the disease from nephrostomy until death.
Survival time after PN ranged from 4 days to 16 months, averaging 4.3 months. 26 patients (52%) had died after 3 months, 41 (82%) after 6 months. The patients had spent on average 44.5% of their remaining life in hospital. After an initial improvement in their state, cancer-produced pain and complications soon set in and often required operative intervention.
The achieved prolongation of survival time did not always meet the patient's own wishes. Detailed explanation and information to patient and family before PN is therefore urgently required.
评估因恶性肿瘤及肾后性无尿而行经皮肾造瘘术（PN）患者的生存时长及生活质量。
分析50例因恶性肿瘤导致肾后性无尿的患者（39例男性，11例女性；平均年龄65.6岁）的病例记录，这些患者在局部麻醉下接受了超声引导下的PN以进行尿液引流。特别关注了从肾造瘘术到死亡的疾病进程。
PN术后生存时间为4天至16个月，平均4.3个月。26例患者（52%）在3个月后死亡，41例（82%）在6个月后死亡。患者平均在医院度过了剩余生命的44.5%。在状态初步改善后，癌症引发的疼痛和并发症很快出现，且常常需要手术干预。
所实现的生存时间延长并不总是符合患者自身的意愿。因此，在PN术前急需向患者及其家属进行详细解释和告知。
